atorvastatin has been researched along with fibrin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chopp, M; Goussev, A; Lu, D; Mahmood, A; Qu, C; Zhang, ZG | 1 |
| Adamson, U; Antovic, A; Henriksson, P; Jörneskog, G; Lins, PE; Mobarrez, F; Santesson, P; Tehrani, S; Wallén, NH | 1 |
| Doi, M; Fukushima, H; Hamada, M; Matsui, H; Mizuno, T; Nishio, K; Shida, Y; Shima, M; Sugimoto, M; Yoshioka, A | 1 |
| Ciesla-Dul, M; Undas, A; Zolcinski, M | 1 |
| Guruprasad, CN; Kumari, M; Martande, SS; Pradeep, AR; Singh, SP; Suke, DK | 1 |
| Ai, A; Ai, J; Ardakan, MMM; Bayat, N; Ebrahimi-Barough, S; Norouzi-Javidan, A; Saberi, H; Shirian, S; Tajerian, R | 1 |
| Ai, A; Ai, J; Bayat, N; Ebrahimi-Barough, S; Izadpanah, R; Mokhtari Ardakan, MM; Norouzi Javidan, A; Saberi, H | 1 |
| Cui, J; Grau, MS; Jaffer, FA; Jhajj, HS; Kessinger, CW; Libby, P; McCarthy, JR; Misra, S | 1 |
2 trial(s) available for atorvastatin and fibrin
| Article | Year |
|---|---|
Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia.
Topics: Adult; Aged; Atorvastatin; Biomarkers; Blood Platelets; C-Reactive Protein; Cell-Derived Microparticles; Cross-Over Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Dyslipidemias; Fibrin; Fibrinolytic Agents; Glycated Hemoglobin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Integrin beta3; Middle Aged; P-Selectin; Plasminogen Activator Inhibitor 1; Pyrroles; Sweden; Thrombin; Thromboplastin; Thrombosis; Time Factors; Treatment Outcome | 2010 |
Platelet-Rich Fibrin Combined With 1.2% Atorvastatin for Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial.
Topics: Alveolar Bone Loss; Atorvastatin; Chronic Periodontitis; Fibrin; Humans; Platelet-Rich Fibrin | 2016 |
6 other study(ies) available for atorvastatin and fibrin
| Article | Year |
|---|---|
Delayed thrombosis after traumatic brain injury in rats.
Topics: Animals; Atorvastatin; Blood Coagulation Factors; Brain; Brain Injuries; Disease Models, Animal; Fibrin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Thrombosis; Male; Pyrroles; Rats; Rats, Wistar; Time Factors | 2004 |
Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions.
Topics: Atorvastatin; Blood Platelets; Dose-Response Relationship, Drug; Fibrin; Fibrinolytic Agents; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; P-Selectin; Perfusion; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Pyrroles; Regional Blood Flow; Stress, Mechanical; Thrombin; Thromboplastin; Thrombosis; Time Factors; von Willebrand Factor | 2011 |
Effects of atorvastatin on plasma fibrin clot properties in apparently healthy individuals and patients with previous venous thromboembolism.
Topics: Atorvastatin; Biomarkers; Blood Coagulation; Blood Coagulation Tests; Case-Control Studies; Dyslipidemias; Fibrin; Fibrinolytic Agents; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Poland; Pyrroles; Treatment Outcome; Ultrasonography, Doppler, Color; Venous Thromboembolism | 2012 |
Apoptotic effect of atorvastatin in glioblastoma spheroids tumor cultured in fibrin gel.
Topics: Antineoplastic Agents; Apoptosis; Atorvastatin; Cell Movement; Dose-Response Relationship, Drug; Fibrin; Gels; Glioblastoma; Humans; Spheroids, Cellular; Tumor Cells, Cultured | 2016 |
The Anti-Angiogenic Effect of Atorvastatin in Glioblastoma Spheroids Tumor Cultured in Fibrin Gel: in 3D in Vitro Model
Topics: Angiogenesis Inhibitors; Anticholesteremic Agents; Atorvastatin; Cell Culture Techniques; Cell Movement; Cells, Cultured; Fibrin; Gels; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Neovascularization, Pathologic; Spheroids, Cellular | 2018 |
Atorvastatin Reduces
Topics: Animals; Arteriovenous Shunt, Surgical; Atorvastatin; Carotid Artery, Internal; Collagen; Female; Fibrin; Fibrosis; Hemorheology; Inflammation; Jugular Veins; Macrophages; Male; Mice; Mice, Inbred C57BL; Molecular Imaging; Nanoparticles; Random Allocation; RNA, Messenger; Thrombosis; Transcription, Genetic; Vascular Access Devices; Vascular Patency | 2020 |